Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded encouraging developments into new therapeutic approaches. Current efforts centers on targeting the underlying pathophysiology of MSA. One avenue under investigation involves pharmacological interventions to regulate the function of